Cell Culture Media Global Market Report 2024

The cell culture media market size has grown rapidly in recent years. It will grow from $4.84 billion in 2023 to $5.46 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth observed in the historical period can be attributed to several key factors. These include the expansion of research and development (R&D) activities, the increasing prevalence of chronic diseases necessitating advanced treatment solutions, the burgeoning biopharmaceutical industry, supportive government initiatives and funding aimed at advancing medical research and development, and the growing demand for regenerative medicine and stem cell therapies as innovative treatment modalities.

The cell culture media market size is expected to see rapid growth in the next few years. It will grow to $8.91 billion in 2028 at a compound annual growth rate (CAGR) of 13%. The anticipated growth in the forecast period can be attributed to several key factors. These include an increasing emphasis on personalized medicine, driven by advancements in genomic research and diagnostics, a robust pipeline of biopharmaceutical products targeting various diseases and conditions, an expanding scope of stem cell research and therapies, and the growing adoption of organ-on-a-chip technology for drug testing and toxicity screening, which promises more accurate and efficient evaluation of pharmaceutical compounds.

The expansion of pharmaceutical drug manufacturing is poised to drive growth in the cell culture media market. This surge is fueled by the rising prevalence of chronic and infectious diseases, along with an aging population, necessitating increased medication demand. Cell culture media play a pivotal role in providing the necessary nutrients and environment for optimal cell growth, crucial in producing therapeutic proteins or molecules. For example, data from June 2023 indicates that bio-pharmaceutical production in Europe saw a 4.95% increase from the previous year, totaling $384.2 billion (€340,000 million) in 2022 according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), highlighting the market's momentum.

Key players in the competitive landscape of the cell culture media market, are prioritizing the development of innovative formulations. Sin July 2023, Lonza Group Ltd., a Switzerland-based healthcare company, launched TheraPRO CHO Media System, an innovative cell culture platform designed to enhance productivity and quality in therapeutic protein manufacture. This cutting-edge platform streamlines therapeutic monoclonal antibody production with its chemically defined, animal-component-free composition, promising improved scalability and productivity in biopharmaceutical manufacturing.

In November 2022, ANGUS Chemical Company bolstered its position in the bioprocessing sector through the acquisition of Expression Systems LLC. This strategic move enhances ANGUS' capability to provide high-quality ingredients and services across all bioprocessing stages, from early development to full-scale commercial production. Expression Systems LLC, a US-based manufacturer of cell culture media and related products, adds value to ANGUS' offerings, strengthening its foothold in the market.

Major companies operating in the cell culture media market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Sartorius AG, CYTIVA Lifesciences, Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Takara Bio, MP Biomedicals, FUJIFILM Irvine Scientific Inc., Promocell Inc., InSphero AG, PeproTech Inc., HiMedia Laboratories Pvt. Ltd., Elabscience Biotechnology Inc., Capricorn Scientific GmbH, CAISSON Laboratories Inc., Cell Biologics Inc., Nucleus Biologics LLC.

North America was the largest region in the cell culture media market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell culture media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell culture media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cell culture media are nutrient-rich solutions crafted to nurture the growth, sustenance, and multiplication of cells outside their natural habitat. These solutions typically comprise a meticulously balanced blend of amino acids, vitamins, minerals, sugars, and growth factors customized to meet the specific needs of different cell types. The composition of the media can vary significantly based on the unique requirements of the cells and the objectives of the experiment or culture process.

The several types in cell culture media are liquid media, semi-solid media, and solid media. Liquid media are fluid-based solutions employed in various manufacturing, research, or operational activities. The different products within cell culture media include serum-free media, classical media, stem cell culture media, specialty media, chemically defined media, and others. These are utilized across diverse applications such as biopharmaceutical production, diagnostics, drug screening and development, tissue engineering, and regenerative medicine. Cell culture media find application among various end-users, including the biotechnology and pharmaceutical industries, academic institutes, research laboratories, and other relevant entities.

The cell culture media market research report is one of a series of new reports that provides cell culture media market statistics, including cell culture media industry global market size, regional shares, competitors with a cell culture media market share, detailed cell culture media market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture media industry. This cell culture media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell culture media market consists of sales of co-culture media, conditioned media, and serum substitute media. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.